We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test Determines Genetic Resistance to HIV

By HospiMedica staff writers
Posted on 07 Jul 2006
A test has been developed that determines if a person is a fast, neutral, or slow progressor to AIDS after human immunodeficiency virus (HIV) infection. More...


The results of the test help individuals infected with HIV know how quickly the virus is likely to cause disease, enabling physicians to decide how aggressive the therapy needs to be for each patient.

The test was developed by Independent Forensics (Jersey City, NJ, USA). It measures the genetics of CCR5 receptors on T-cells and uses a simple buccal swab collection procedure, which can be easily carried out at home. Test results are available in three weeks. CCR5 is the primary HIV receptor in T-cells, and people contain varying amounts of this receptor according to their genetic make-up. The fewer available CCR5 receptors people have, the more likely it is that they will demonstrate a slow progression to AIDS when infected with HIV-1.

"We believe the CCR5 halotype test is one of the most important things an individual with HIV can do to help in their treatment. It is part of our philosophy to 'Know Thyself', knowing your own genetic makeup will help everyone make informed and healthy life decisions,” explained Jack Keehma, CEO of Independent Forensics.

Independent Forensics' services include paternity, immigration, Codis data basing, casework, expert witness testimony, and product development for the forensic community. The company's products include SampleTrak software and rapid-stain identification tests for saliva and semen.



Related Links:
Independent Forensics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.